Water-soluble l-cysteine-coated FePt nanoparticles as dual MRI/CT imaging contrast agent for glioma

International Journal of Nanomedicine

Volumn 10, Issue , 2015, Pages 2325-2333

  Liang, Shu Yan ^a   Zhou, Qing ^a   Wang, Min ^b   Zhu, Yan Hong ^a   Wu, Qing Zhi ^b   Yang, Xiang Liang ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b WUHAN UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

CT; Glioma; MRI

Indexed keywords

CONTRAST MEDIUM; IOHEXOL; LEVO CYSTEINE COATED IRON PLATINUM NANOPARTICLE; NANOPARTICLE; UNCLASSIFIED DRUG; CYSTEINE; IRON; METAL NANOPARTICLE; PLATINUM;

ARTICLE; BIOCOMPATIBILITY; CELL VIABILITY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CYTOTOXICITY; DRUG STRUCTURE; DRUG SYNTHESIS; EMBRYO; GLIOMA; GLIOMA CELL LINE; HUMAN; HUMAN CELL; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTICLE SIZE; CHEMISTRY; HEK293 CELL LINE; METABOLISM; PROCEDURES; X-RAY COMPUTED TOMOGRAPHY;

CONTRAST MEDIA; CYSTEINE; GLIOMA; HEK293 CELLS; HUMANS; IRON; MAGNETIC RESONANCE IMAGING; METAL NANOPARTICLES; PLATINUM; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84928155010     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S75174     Document Type: Article

References (46)

1. Wen PY, Kesari S. Malignant gliomas in adults. N Engl J Med. 2008;359(5):492-509.
2. Orringer DA, Koo YE, Chen T, Kopelman R, Sagher O, Philbert MA. Small solutions for big problems: the application of nanoparticles to brain tumor diagnosis and therapy. Clin Pharmacol Ther. 2009;85(5):531-534.
3. Rozhkova EA. Nanoscale materials for tackling brain cancer: recent progress and outlook. Adv Mater. 2011;23(24):H136-H150.
4. Li M, Deng H, Peng H, Wang Q. Functional nanoparticles in targeting gliomas diagnosis and therapies. J Nanosci Nanotechnol. 2014;14(1):415-432.
5. Cheng Y, Morshed RA, Auffinger B, Tobias AL, Lesniak MS. Multifunctional nanoparticles for brain tumor imaging and therapy. Adv Drug Deliv Rev. 2014;66:42-57.
6. Su Z, Xing L, Chen Y, et al. Lactoferrin-modified poly(ethylene glycol)-grafted BSA nanoparticles as a dual-targeting carrier for treating brain gliomas. Mol Pharm. 2014;11(6):1823-1834.
7. Chung EJ, Cheng Y, Morshed R, et al. Fibrin-binding, peptide amphiphile micelles for targeting glioblastoma. Biomaterials. 2014;35(4):1249-1256.
8. Yang ZZ, Li JQ, Wang ZZ, Dong DW, Qi XR. Tumor-targeting dual peptides-modified cationic liposomes for delivery of siRNA and docetaxel to gliomas. Biomaterials. 2014;35(19):5226-5239.
9. Kang T, Gao X, Hu Q, et al. iNGR-modified PEG-PLGA nanoparticles that recognize tumor vasculature and penetrate gliomas. Biomaterials. 2014;35(14):4319-4332.
10. You J, Shao R, Wei X, Gupta S, Li C. Near-infrared light triggers release of paclitaxel from biodegradable microspheres: photothermal effect and enhanced antitumor activity. Small. 2010;6(9):1022-1031.
11. Silva AC, Oliveira TR, Mamani JB, et al. Application of hyperthermia induced by superparamagnetic iron oxide nanoparticles in glioma treatment. Int J Nanomedicine. 2011;6:591-603.
12. Hainfeld JF, Smilowitz HM, O'Connor MJ, Dilmanian FA, Slatkin DN. Gold nanoparticle imaging and radiotherapy of brain tumors in mice. Nanomedicine (Lond). 2013;8(10):1601-1609.
13. Cheng Y, Morshed R, Cheng SH, et al. Nanoparticle-programmed self-destructive neural stem cells for glioblastoma targeting and therapy. Small. 2013;9(24):4123-4129.
14. Bechet D, Mordon SR, Guillemin F, Barberi-Heyob MA. Photodynamic therapy of malignant brain tumors: a complementary approach to conventional therapies. Cancer Treat Rev. 2014;40(2):229-241.
15. Yi GQ, Gu B, Chen LK. The safety and efficacy of magnetic nano-iron hyperthermia therapy on rat brain gliomas. Tumor Biol. 2014;35(3):2445-2449.
16. Mohamed MS, Veeranarayanan S, Poulose AC, et al. Type 1 ribotoxin-curcin conjugated biogenic gold nanoparticles for a multimodal therapeutic approach towards brain cancer. Biochim Biophys Acta. 2014;1840(6):1657-1669.
17. Veiseh O, Sun C, Gunn J, et al. Optical and MRI multifunctional nanoprobe for targeting gliomas. Nano Lett. 2005;5(6):1003-1008.
18. Chertok B, Moffat BA, David AE, et al. Iron oxide nanoparticles as a drug delivery vehicle for MRI monitored magnetic targeting of brain tumors. Biomaterials. 2008;29(4):487-496.
19. Ray A, Wang X, Lee YK, et al. Targeted blue nanoparticles as photoacoustic contrast agent for brain tumor delineation. Nano Res. 2011;4(11):1163-1173.
20. Xiao N, Gu W, Wang H, Deng YL, Shi X, Ye L. T1-T2 dual-modal MRI of brain gliomas using PEGylated Gd-doped iron oxide nanoparticles. J Colloid Interface Sci. 2014;417:159-165.
21. Ni D, Zhang J, Bu W, et al. Dual-targeting upconversion nanoprobes across the blood-brain barrier for magnetic resonance/fluorescence imaging of intracranial glioblastoma. ACS Nano. 2014;8(2):1231-1242.
22. Deng Y, Wang H, Gu W, et al. Ho3+ doped NaGdF4 nanoparticles as MRI/optical probes for brain gliomas imaging. Journal of Materials Chemistry B. 2014;2:1521-1529.
23. Shevtsov MA, Nikolaev BP, Yakovleva LY, et al. Superparamagnetic iron oxide nanoparticles conjugated with epidermal growth factor (SPION-EGF) for targeting brain tumors. Int J Nanomedicine. 2014;9:273-287.
24. Chertok B, David AE, Yang VC. Brain tumor targeting of magnetic nanoparticles for potential drug delivery: effect of administration route and magnetic field topography. J Control Release. 2011;155(3):393-399.
25. Xie H, Zhu Y, Jiang W, et al. Lactoferrin-conjugated superparamagnetic iron oxide nanoparticles as a specific MRI contrast agent for detection of brain glioma in vivo. Biomaterials. 2011;32(2):495-502.
26. Sun C, Fang C, Stephen Z, et al. Tumor-targeted drug delivery and MRI contrast enhancement by chlorotoxin-conjugated iron oxide nanoparticles. Nanomedicine (Lond). 2008;3(4):495-505.
27. Gao J, Gu H, Xu B. Multifunctional magnetic nanoparticles: design, synthesis, and biomedical applications. Acc Chem Res. 2009;42(8):1097-1107.
28. Frey NA, Peng S, Cheng K, Sun SH. Magnetic nanoparticles: synthesis, functionalization, and applications in bioimaging and magnetic energy storage. Chem Soc Rev. 2009;38(9):2532-2542.
29. Ho D, Sun X, Sun S. Monodisperse magnetic nanoparticles for theranostic applications. Acc Chem Res. 2011;44(10):875-882.
30. Gao J, Liang G, Cheung JS, et al. Multifunctional yolk-shell nanoparticles: a potential MRI contrast and anticancer agent. J Am Chem Soc. 2008;130(35):11828-11833.
31. Chen S, Wang L, Duce SL, et al. Engineered biocompatible nanoparticles for in vivo imaging application. J Am Chem Soc. 2010;132(42):15022-15029.
32. Chou SW, Shau YH, Wu PC, Yang YS, Shieh DB, Chen CC. In vitro and in vivo studies of FePt nanoparticles for dual modal CT/MRI molecular imaging. J Am Chem Soc. 2010;132(38):13270-13278.
33. Yang H, Zhang J, Tian Q, et al. One-pot synthesis of amphiphilic superparamagnetic FePt nanoparticles and magnetic resonance imaging in vitro. J Magn Magn Mater. 2010;322(8):973-977.
34. Koch F, Möller AM, Frenz M, Peiles U, Kuehni-Boghenbor K, Mevissen M. An in vitro toxicity evaluation of gold-, PLLA- and PCL-coated silica nanoparticles in neuronal cells for nanoparticle-assisted laser-tissue soldering. Toxicol In Vitro. 2014;28(5):990-998.
35. Hou Y, Lai M, Chen X, et al. Effects of mesoporous SiO2, Fe3 O4, and TiO2 nanoparticles on the biological functions of endothelial cells in vitro. J Biomed Mater Res A. 2014;102(6):1726-1736.
36. Bellusci M, La Barbera A, Padella F, et al. Biodistribution and acute toxicity of a nanofluid containing manganese iron oxide nanoparticles produced by a mechanochemical process. Int J Nanomedicine. 2014;9:1919-1929.
37. Sharma HS, Muresanu DF, Patnaik R, Sharma A. Exacerbation of brain pathology after partial restraint in hypertensive rats following SiO2 nanoparticles exposure at high ambient temperature. Mol Neurobiol. 2013;48(2):368-379.
38. Wu J, Ding T, Sun J. Neurotoxic potential of iron oxide nanoparticles in the rat brain striatum hippocampus. Neurotoxicology. 2013;34:243-253.
39. Sun H, Chen X, Chen D, et al. Influences of surface coatings and components of FePt nanoparticles on the suppression of gliomas cell proliferation. Int J Nanomedicine. 2012;7:3295-3307.
40. Zhang K, Yu Y, Sun S. Facile synthesis L-cysteine capped CdS:Eu quantum dots and their Hg2+ sensitive properties. Appl Surface Sci. 2013;276:333-339.
41. Aryal S, B K C R, Dharmaraj N, Bhattarai N, Kim CH, Kim HY. Spectroscopic identification of S-Au interaction in cysteine capped gold nanoparticles. Spectrochim Acta A Mol Biomol Spectrosc. 2006;63(1):160-163.
42. Chandra S, Saleem H, Sebastian S, Sundaraganesan N. The spectroscopic (FT-IR, FT-Raman), NCA, first order hyperpolarizability, NBO analysis, HOMO and LUMO analysis of L-cysteine by ab inito HF and density functional method. Spectrochim Acta A Mol Biomol Spectrosc. 2011;78(5):1515-1524.
43. Zhu X, Mason TG. Nanoparticle size distributions measured by optical adaptive-deconvolution passivated-gel electrophoresis. J Colloid Interface Sci. 2014;435:67-74.
44. Wu XW, Liu C, Li L, Jones P, Chantrell RW, Weller D. Nonmagnetic shell in surfactant-coated FePt nanoparticles. J Appl Phys. 2004;95(11);6810-6812.
45. Aslam M, Fu L, Li S, Dravid VP. Silica encapsulation and magnetic properties of FePt nanoparticles. J Colloid Interface Sci. 2005;290;444-449.
46. Yu ACC, Mizuno M, Sasaki Y, Kondo H. Atomic composition effect on the ordering of solution-phase synthesized FePt nanoparticle films. Appl Phys Lett. 2004;85(25);6242-6244.